Our findings not only enrich the current understanding of CD44's regulation of the EMT but also suggest that this molecule plays an important role in both maintaining the mesenchymal phenotype and participating in HCC dissemination, demonstrating the potential for establishing CD44-targeted molecular therapy of HCC. The gene discussed is CD44; the disease is hepatocellular carcinoma.